SELENOF and malignant colon neoplasm: Because aberrant crypt foci serve as a surrogate biomarker for colon cancer risk in humans [20], these results indicate that, unlike previous observations in human mesothelioma cells [12], a lack of Sep15 expression may be protective against colon tumor formation in vivo.